Literature DB >> 8178456

Differential expression of viral and human interleukin-10 (IL-10) by primary B cell tumors and B cell lines.

J P Stewart1, F G Behm, J R Arrand, C M Rooney.   

Abstract

Human and viral interleukin-10 (IL-10) possess growth factor activity for human B cells and may act as autocrine growth factors in B cell malignancies. To study this possibility we have measured viral (v) and human (h) IL-10 expression in EBV-positive and negative B lineage tumors and tumor cell lines. Previous studies demonstrated IL-10 expression in cell lines and now we describe the pattern of IL-10 expression in primary Burkitt's lymphoma (BL) tumor biopsies and in BL lines of defined phenotypes. vIL-10 was expressed during the lytic (productive) phase of EBV infection, but not during virus latency. Although hIL-10 was expressed in the majority of B cell lines, it was not expressed in two BL biopsy specimens. Expression of hIL-10 did not correlate with the presence of EBV, but was associated with the differentiation state of the B cell line. Thus, vIL-10 may enhance the persistence of B cells infected at sites of virus replication, and while hIL-10 may be a factor in the growth both in vivo and in vitro of some BLs and EBV-transformed B cells, it is not an absolute requirement.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8178456     DOI: 10.1006/viro.1994.1236

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  12 in total

1.  A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas.

Authors:  Shi-Dong Ma; Subramanya Hegde; Ken H Young; Ruth Sullivan; Deepika Rajesh; Ying Zhou; Ewa Jankowska-Gan; William J Burlingham; Xiaoping Sun; Margaret L Gulley; Weihua Tang; Jenny E Gumperz; Shannon C Kenney
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

2.  Characterization of tumor cell lines derived from murine gammaherpesvirus-68-infected mice.

Authors:  E J Usherwood; J P Stewart; A A Nash
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

3.  Type I insulin-like growth factor receptor gene expression in normal human breast tissue treated with oestrogen and progesterone.

Authors:  R B Clarke; A Howell; E Anderson
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

4.  Identification and characterization of murine gammaherpesvirus 68 gp150: a virion membrane glycoprotein.

Authors:  J P Stewart; N J Janjua; S D Pepper; G Bennion; M Mackett; T Allen; A A Nash; J R Arrand
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

5.  Dithiocarbamates and viral IL-10 collaborate in the immortalization and evasion of immune response in EBV-infected human B lymphocytes.

Authors:  Richard D Irons; Anh Tuan Le
Journal:  Chem Biol Interact       Date:  2007-11-22       Impact factor: 5.192

6.  Characterization of murine gammaherpesvirus 68 glycoprotein B (gB) homolog: similarity to Epstein-Barr virus gB (gp110).

Authors:  J P Stewart; N J Janjua; N P Sunil-Chandra; A A Nash; J R Arrand
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

Review 7.  Post-transplant lymphoproliferative disease (PTLD): lymphokine production and PTLD.

Authors:  G Tosato; J Teruya-Feldstein; J Setsuda; S E Pike; K D Jones; E S Jaffe
Journal:  Springer Semin Immunopathol       Date:  1998

8.  Interleukin-6 and interleukin-10 gene promoter polymorphisms and risk of endemic Burkitt lymphoma.

Authors:  Cliff I Oduor; Kiprotich Chelimo; Collins Ouma; David H Mulama; Joslyn Foley; John Vulule; Jeffrey A Bailey; Ann M Moormann
Journal:  Am J Trop Med Hyg       Date:  2014-07-28       Impact factor: 2.345

Review 9.  Herpesvirus exploitation of host immune inhibitory pathways.

Authors:  Gabrielle Stack; Maria A Stacey; Ian R Humphreys
Journal:  Viruses       Date:  2012-08-03       Impact factor: 5.048

10.  The vIL-10 gene of the Epstein-Barr virus (EBV) is conserved in a stable manner except for a few point mutations in various EBV isolates.

Authors:  Kyosuke Kanai; Yukio Satoh; Hiroyuki Yamanaka; Asako Kawaguchi; Kazutaka Horie; Kenji Sugata; Yoshiko Hoshikawa; Tetsutaro Sata; Takeshi Sairenji
Journal:  Virus Genes       Date:  2007-08-31       Impact factor: 2.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.